Department of Optometry and Visual Science, West China School of Medicine, Sichuan University, Chengdu, China.
Department of Optometry and Visual Science, West China School of Medicine, Sichuan University, Chengdu, China.
Cont Lens Anterior Eye. 2020 Dec;43(6):595-601. doi: 10.1016/j.clae.2020.03.016. Epub 2020 May 1.
To report the study design and one month's preliminary results of a randomized, single-masked, one-year prospective study of orthokeratology (ortho-k) in adults wearing lenses of different compression factors.
Adults aged 18-38 years, with myopia of -0.75 to -5.00 D and astigmatism < 1.50 D, were recruited and randomly assigned into two groups: a conventional compression factor or Jessen Factor (CCF) group (compression factor = 0.75 D) and an increased (extra 1.00D) compression factor (ICF) group. Clinical outcomes, including spherical equivalent refraction (SER) reduction, visual acuity, corneal hysteresis (CH) and corneal resistance factor (CRF), and signs and symptoms were collected at the one-month follow-up visit. Indicators of the level of satisfaction and quality of life after commencing treatment were determined via a satisfaction questionnaire and the NEI-RQL-42 questionnaire.
Baseline data from 26 CCF and 24 ICF participants were analysed and no significant differences were observed between the two groups (p > 0.05). The first fit success rates were 90 % for CCF group and 83 % for the ICF group, SER reductions were 97 % and 95 % for the CCF and ICF group, respectively, with uncorrected high-contrast visual acuity of -0.06 (-0.18 to 0.42) and 0.00 (-0.16 to 0.52), respectively (p > 0.05) at the 1-month visit. Overall, the incidence of corneal staining was 77 % in the CCF and 79 % in ICF group; central corneal staining was 15 % and 33 %, respectively. However, the differences of corneal staining between the groups did not reach significance in any visit (p > 0.05). The main complaint from participants was glare (both groups). No significant differences in CRF and CH were found in the first month (p > 0.05). Both groups recorded high scores in the level of satisfaction questionnaire, with no significant differences between groups (p > 0.05). Compared with baseline scores, 1-month NEI-RQL-42 subscales of dependence on correction, appearance, and satisfaction with correction significantly increased, and the glare score significantly decreased in both groups (all p < 0.05).
The majority of participants were satisfied with the treatment and no serious corneal adverse effects were observed. These results demonstrate that ortho-k lenses of default and increased compression factor (1D) demonstrated similar clinical performance and ortho-k can be a safe and well-accepted option for myopia correction in adults, but long-term observation is warranted.
报告一项角膜塑形术(ortho-k)治疗成年人的随机、单盲、为期一年的前瞻性研究的设计和一个月的初步结果,这些成年人戴的镜片具有不同的压缩系数。
招募年龄在 18-38 岁之间、近视屈光度在-0.75 至-5.00 D 之间且散光<1.50 D 的成年人,并将其随机分为两组:常规压缩系数或 Jessen 系数(CCF)组(压缩系数=0.75 D)和增加(额外 1.00 D)压缩系数(ICF)组。在一个月的随访时,收集临床结果,包括球镜等效屈光度(SER)降低、视力、角膜滞后(CH)和角膜阻力因子(CRF)以及体征和症状。通过满意度问卷和 NEI-RQL-42 问卷确定开始治疗后的满意度和生活质量水平的指标。
对 26 名 CCF 和 24 名 ICF 参与者的基线数据进行了分析,两组之间没有观察到显著差异(p>0.05)。CCF 组的首次适配成功率为 90%,ICF 组为 83%,SER 降低分别为 CCF 组的 97%和 ICF 组的 95%,未经矫正的高对比度视力分别为-0.06(-0.18 至 0.42)和 0.00(-0.16 至 0.52)(p>0.05)。总的来说,CCF 组角膜染色的发生率为 77%,ICF 组为 79%;中央角膜染色分别为 15%和 33%。然而,在任何一次就诊时,两组间的角膜染色差异均无统计学意义(p>0.05)。参与者的主要抱怨是眩光(两组均有)。在第一个月内,CRF 和 CH 无显著差异(p>0.05)。两组在满意度问卷中的得分均较高,组间无显著差异(p>0.05)。与基线评分相比,两组的 1 个月 NEI-RQL-42 子量表的依赖矫正、外观和矫正满意度显著增加,眩光评分显著降低(均 p<0.05)。
大多数参与者对治疗满意,未观察到严重的角膜不良反应。这些结果表明,默认和增加压缩系数(1D)的 ortho-k 镜片具有相似的临床效果,ortho-k 可以成为成年人近视矫正的一种安全且可接受的选择,但需要长期观察。